Get the Stockscreener App
0.7484
15.91%
-0.1416
Pre-market:
.79
0.0416
+5.56%
Passage Bio Inc Stock (PASG) Forecast
The Passage Bio Inc (PASG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.568, representing a +376.74% increase from the current price of $0.7484. The highest analyst price target is $4.3164, and the lowest is $2.8195.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PASG Price Target
Average 7.0902
(+847.38% Upside)
Is Passage Bio Inc (PASG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.72 | Neutral |
| STOCH(9,6) | 62.42 | Neutral |
| STOCHRSI(14) | 46.69 | Neutral |
| MACD(12,26) | 0.0661 | Buy |
| ADX(14) | 32.76 | Buy |
| William %R | -66.17 | Neutral |
| CCI(14) | 54.70 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7372
Buy
|
0.775
Sell
|
| MA20 |
0.6623
Buy
|
0.7077
Buy
|
| MA50 |
0.636
Buy
|
0.6771
Buy
|
| MA100 |
0.7104
Buy
|
0.7368
Buy
|
| MA200 |
0.9825
Sell
|
0.804
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, PASG could be considered a Strong Buy, with 17 technical analysis indicators signaling 9 Buy signals, 3 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on PASG, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 52.72 indicates that PASG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 62.42 indicates that PASG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.69 indicates that PASG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.76 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 54.7 indicates that PASG is still overbought but not to an extreme extent.
Long-term PASG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Passage Bio Inc financial reports and earnings history, Passage Bio Inc (PASG) stock could reach $6.4619 by 2030, $46.68 by 2040 and $68.87 by 2050. See the projected annual prices until 2050 of the Passage Bio Inc stock below:
- Passage Bio Inc (PASG) is expected to reach an average price of $30.42 in 2035, with a high prediction of $29.87 and a low estimate of $29.08. This indicates an $3,965% rise from the last recorded price of $0.7484.
- Passage Bio Inc (PASG) stock is projected to chart a bullish course in 2040, with an average price target of $45.44, representing an $5,971% surge from its current level. The forecast ranges from a conservative $45.67 to a sky-high $46.68.
- Our analysts predict Passage Bio Inc (PASG) to jump 7,641% by 2045, soaring from $58.21 to an average price of $57.93, potentially reaching $58.13. While $58.21 is the low estimate, the potential upside is significant.
- Passage Bio Inc (PASG) stock is expected to climb by 2050, reaching an average of $69.49, a $9,185% jump from its current level. However, a wide range of estimates exists, with high and low targets of $68.87 and $69.98, respectively, highlighting the market's uncertainty.
Passage Bio Inc Stock (PASG) Year by Year Forecast
Passage Bio Inc Stock (PASG) Price Forecast for 2025
Passage Bio Inc Stock (PASG) is expected to reach an average price of $7.0902 in 2025, with a high prediction of $14.13 and a low estimate of $0.0545. This indicates an +847.38% rise from the last recorded price of $0.7484.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.0595 | $2.8195 | $4.3164 | -92.05% |
| February, 2025 | $0.7037 | $1.1916 | $0.8294 | -5.98% |
| March, 2025 | $7.5522 | $0.4658 | $7.5722 | +909.11% |
| April, 2025 | $10.60 | $6.6111 | $12.84 | +1,316% |
| May, 2025 | $5.0728 | $1.6688 | $14.13 | +577.82% |
| June, 2025 | $3.6386 | $0.6397 | $6.8507 | +386.19% |
| July, 2025 | $1.1734 | $0.0545 | $6.0866 | +56.79% |
| August, 2025 | $3.2793 | $0.1036 | $4.3593 | +338.17% |
| September, 2025 | $1.9149 | $0.1178 | $3.7082 | +155.86% |
| October, 2025 | $1.5301 | $0.888 | $1.4185 | +104.45% |
| November, 2025 | $1.7242 | $0.8911 | $1.4489 | +130.39% |
| December, 2025 | $2.1594 | $2.7363 | $2.1284 | +188.54% |
Passage Bio Inc Stock (PASG) Price Forecast for 2026
The predicted value for Passage Bio Inc (PASG) in 2026 is set at an average of $5.4739. Estimates vary from a peak of $8.5573 to a trough of $2.3905, indicating an +631.41% surge from the present price of $0.7484.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0836 | $2.3905 | $1.8826 | +178.41% |
| February, 2026 | $4.0778 | $3.4046 | $3.2767 | +444.86% |
| March, 2026 | $3.5419 | $4.2388 | $4.0909 | +373.26% |
| April, 2026 | $5.5371 | $4.913 | $4.8771 | +639.86% |
| May, 2026 | $6.0513 | $5.7282 | $5.6913 | +708.56% |
| June, 2026 | $7.3754 | $6.7323 | $6.9154 | +885.49% |
| July, 2026 | $8.2506 | $7.3065 | $7.9956 | +1,002% |
| August, 2026 | $8.1348 | $8.3217 | $8.3038 | +986.96% |
| September, 2026 | $8.09 | $7.849 | $8.0058 | +980.97% |
| October, 2026 | $8.8342 | $8.421 | $8.4805 | +1,080% |
| November, 2026 | $8.1283 | $8.5983 | $8.5573 | +986.09% |
| December, 2026 | $7.5735 | $7.6435 | $7.7804 | +911.96% |
Passage Bio Inc Stock (PASG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Passage Bio Inc (PASG) is $6.1661, with a high forecast of $7.4746 and a low forecast of $4.8576. This indicates an +723.90% increase from the last price of $0.7484.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.7677 | $7.5746 | $7.4177 | +937.90% |
| February, 2027 | $7.3118 | $7.3318 | $7.2687 | +877.00% |
| March, 2027 | $7.647 | $7.2639 | $7.307 | +921.78% |
| April, 2027 | $7.3512 | $7.4212 | $7.4746 | +882.25% |
| May, 2027 | $6.8354 | $7.1743 | $7.1333 | +813.33% |
| June, 2027 | $6.8306 | $6.8095 | $6.7685 | +812.69% |
| July, 2027 | $5.7047 | $6.1747 | $6.4626 | +662.25% |
| August, 2027 | $5.8089 | $5.8689 | $5.7489 | +676.17% |
| September, 2027 | $5.6441 | $5.7041 | $5.6734 | +654.15% |
| October, 2027 | $5.5182 | $5.5382 | $5.4272 | +637.34% |
| November, 2027 | $5.2673 | $5.2674 | $5.3293 | +603.81% |
| December, 2027 | $4.8319 | $4.8576 | $5.0434 | +545.63% |
Passage Bio Inc Stock (PASG) Price Forecast for 2028
In 2028, Passage Bio Inc (PASG) is projected to reach an average price of $2.6051, with a high projection of $4.7186 and a low estimate of $0.4917. This indicates an +248.10% rise from the last price of $0.7484.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.5702 | $4.6315 | $4.7186 | +510.67% |
| February, 2028 | $4.2109 | $4.3059 | $4.4928 | +462.65% |
| March, 2028 | $4.006 | $4.0211 | $4.0869 | +435.28% |
| April, 2028 | $3.7313 | $3.7353 | $3.8933 | +398.57% |
| May, 2028 | $3.4606 | $3.5003 | $3.6119 | +362.40% |
| June, 2028 | $3.1546 | $3.1646 | $3.3125 | +321.52% |
| July, 2028 | $2.8588 | $2.8947 | $2.9957 | +281.99% |
| August, 2028 | $2.0978 | $2.3629 | $2.6724 | +180.30% |
| September, 2028 | $1.8692 | $1.9076 | $1.935 | +149.77% |
| October, 2028 | $1.4548 | $1.4823 | $1.7192 | +94.39% |
| November, 2028 | $0.6075 | $0.5465 | $1.0433 | -18.83% |
| December, 2028 | $0.3117 | $0.4917 | $0.4385 | -58.36% |
Passage Bio Inc Stock (PASG) Price Forecast for 2029
The 2029 price forecast for Passage Bio Inc Stock (PASG) is $13.23 on average, with a high prediction of $26.38 and a low estimate of $0.0739. This represents an +1,667% increase from the previous price of $0.7484.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.1441 | $0.0739 | $0.2142 | -80.75% |
| February, 2029 | $31.44 | $21.54 | $26.38 | +4,100% |
| March, 2029 | $23.51 | $25.68 | $24.75 | +3,042% |
| April, 2029 | $22.07 | $23.16 | $21.96 | +2,849% |
| May, 2029 | $15.86 | $17.28 | $18.63 | +2,020% |
| June, 2029 | $11.21 | $11.54 | $12.69 | +1,398% |
| July, 2029 | $20.92 | $12.73 | $15.81 | +2,695% |
| August, 2029 | $21.10 | $22.48 | $22.04 | +2,719% |
| September, 2029 | $20.68 | $20.65 | $19.86 | +2,663% |
| October, 2029 | $17.91 | $20.67 | $22.40 | +2,293% |
| November, 2029 | $18.24 | $18.88 | $17.98 | +2,337% |
| December, 2029 | $9.6657 | $13.85 | $17.41 | +1,192% |
Passage Bio Inc Stock (PASG) Price Forecast for 2030
Passage Bio Inc Stock (PASG) is expected to reach an average price of $12.61 in 2030, with a high forecast of $17.28 and a low forecast of $7.9382. This signifies an +1,585% surge from the last price of $0.7484.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.2261 | $8.3198 | $6.4619 | +731.92% |
| February, 2030 | $11.43 | $7.9382 | $11.06 | +1,428% |
| March, 2030 | $12.55 | $12.62 | $11.92 | +1,577% |
| April, 2030 | $14.27 | $12.96 | $14.00 | +1,807% |
| May, 2030 | $12.20 | $14.02 | $13.77 | +1,530% |
| June, 2030 | $17.08 | $14.59 | $15.56 | +2,182% |
| July, 2030 | $16.30 | $15.82 | $16.50 | +2,078% |
| August, 2030 | $16.18 | $15.58 | $15.64 | +2,062% |
| September, 2030 | $16.97 | $17.03 | $16.27 | +2,167% |
| October, 2030 | $15.83 | $16.37 | $15.95 | +2,015% |
| November, 2030 | $17.51 | $17.07 | $16.78 | +2,239% |
| December, 2030 | $16.65 | $17.58 | $17.28 | +2,125% |
0.23%
3.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):